(Sharecast News) - AstraZeneca and Japan's Daiichi Sankyo announced on Monday that their jointly developed Datroway breast cancer treatment achieved positive results in a phase III trial.
Results from the TROPION-Breast02 trial showed the drug achieved a "statistically significant and clinically meaningful improvement" in overall survival as a first-line therapy for...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE